Search Results

There are 1179 results for: content related to: Novel therapeutics for the management of castration-resistant prostate cancer (CRPC)

  1. You have full text access to this OnlineOpen article
    Targeting the adaptive molecular landscape of castration-resistant prostate cancer

    EMBO Molecular Medicine

    Volume 7, Issue 7, July 2015, Pages: 878–894, Alexander W Wyatt and Martin E Gleave

    Article first published online : 20 APR 2015, DOI: 10.15252/emmm.201303701

  2. You have free access to this content
    New developments in castrate-resistant prostate cancer

    BJU International

    Volume 109, Issue s6, June 2012, Pages: 22–32, N. Shore, M. Mason and Th. M. de Reijke

    Article first published online : 4 JUN 2012, DOI: 10.1111/j.1464-410X.2012.11217.x

  3. You have free access to this content
    Clinical development of novel therapeutics for castration-resistant prostate cancer

    CA: A Cancer Journal for Clinicians

    Volume 62, Issue 5, September/October 2012, Pages: 299–308, Matthew D. Galsky, Alexander C. Small, Che-kai Tsao and William K. Oh

    Article first published online : 24 APR 2012, DOI: 10.3322/caac.21141

  4. You have free access to this content
    Characterising the castration-resistant prostate cancer population: a systematic review

    International Journal of Clinical Practice

    Volume 65, Issue 11, November 2011, Pages: 1180–1192, M. Kirby, C. Hirst and E. D. Crawford

    Article first published online : 14 OCT 2011, DOI: 10.1111/j.1742-1241.2011.02799.x

  5. Emerging treatment options for patients with castration-resistant prostate cancer

    The Prostate

    Volume 72, Issue 3, February 2012, Pages: 338–349, Daniel George and Judd W. Moul

    Article first published online : 11 JUL 2011, DOI: 10.1002/pros.21435

  6. You have free access to this content
    Castration-resistant prostate cancer: Many treatments, many options, many challenges ahead

    Cancer

    Volume 118, Issue 10, 15 May 2012, Pages: 2583–2593, Jorge A. Garcia and Brian I. Rini

    Article first published online : 28 OCT 2011, DOI: 10.1002/cncr.26582

  7. You have free access to this content
    Urologists and oncologists: adapting to a new treatment paradigm in castration-resistant prostate cancer (CRPC)

    BJU International

    Volume 110, Issue 3, August 2012, Pages: 328–335, A. Oliver Sartor and John M. Fitzpatrick

    Article first published online : 19 JUN 2012, DOI: 10.1111/j.1464-410X.2011.10818.x

  8. Somatic copy number alterations by whole-exome sequencing implicates YWHAZ and PTK2 in castration-resistant prostate cancer

    The Journal of Pathology

    Volume 231, Issue 4, December 2013, Pages: 505–516, Roopika Menon, Mario Deng, Kerstin Rüenauver, Angela Queisser, Martin Pfeifer, Anne Offermann, Diana Boehm, Wenzel Vogel, Veit Scheble, Falko Fend, Glen Kristiansen, Nicolas Wernert, Nicole Oberbeckmann, Saskia Biskup, Mark A Rubin, Zaki Shaikhibrahim and Sven Perner

    Article first published online : 12 NOV 2013, DOI: 10.1002/path.4274

  9. You have full text access to this OnlineOpen article
    Enzalutamide: targeting the androgen signalling pathway in metastatic castration-resistant prostate cancer

    BJU International

    Volume 117, Issue 2, February 2016, Pages: 215–225, Jack Schalken and John M. Fitzpatrick

    Article first published online : 6 JUN 2015, DOI: 10.1111/bju.13123

  10. The presence and clinical implication of intraductal carcinoma of prostate in metastatic castration resistant prostate cancer

    The Prostate

    Volume 75, Issue 12, September 1, 2015, Pages: 1247–1254, Zhibin Chen, Ni Chen, Pengfei Shen, Jing Gong, Xiang Li, Tao Zhao, Banghua Liao, Liangren Liu, Zhenhua Liu, Xingming Zhang, Jiyan Liu, Zhufeng Peng, Xueqin Chen, Miao Xu, Haojun Gui, Peng Zhang, Qiang Wei, Qiao Zhou and Hao Zeng

    Article first published online : 27 APR 2015, DOI: 10.1002/pros.23005

  11. You have free access to this content
    Clinical predictors of survival in men with castration-resistant prostate cancer

    Cancer

    Volume 119, Issue 16, 15 August 2013, Pages: 2990–2998, Mari Nakabayashi, Julia Hayes, Mary-Ellen Taplin, Patrick Lefebvre, Marie-Helene Lafeuille, Mark Pomerantz, Christopher Sweeney, Mei Sheng Duh and Philip W. Kantoff

    Article first published online : 29 MAY 2013, DOI: 10.1002/cncr.28102

  12. The altered expression of MiR-221/-222 and MiR-23b/-27b is associated with the development of human castration resistant prostate cancer

    The Prostate

    Volume 72, Issue 10, 1 July 2012, Pages: 1093–1103, Tong Sun, Ming Yang, Shaoyong Chen, Steven Balk, Mark Pomerantz, Chen-Lin Hsieh, Myles Brown, Gwo-Shu Mary Lee and Philip W. Kantoff

    Article first published online : 29 NOV 2011, DOI: 10.1002/pros.22456

  13. You have free access to this content
    Role of targeted therapy in the treatment of advanced prostate cancer

    BJU International

    Volume 105, Issue 6, March 2010, Pages: 748–767, Karim Fizazi, Cora N. Sternberg, John M. Fitzpatrick, R. William Watson and Majid Tabesh

    Article first published online : 25 FEB 2010, DOI: 10.1111/j.1464-410X.2010.09236.x

  14. Testosterone boosts for treatment of castration resistant prostate cancer: An experimental implementation of intermittent androgen deprivation

    The Prostate

    Volume 73, Issue 15, November 2013, Pages: 1699–1709, Paul Thelen, Elmar Heinrich, Felix Bremmer, Lutz Trojan and Arne Strauss

    Article first published online : 19 JUL 2013, DOI: 10.1002/pros.22711

  15. Variant allele of HSD3B1 increases progression to castration-resistant prostate cancer

    The Prostate

    Volume 75, Issue 7, May 15, 2015, Pages: 777–782, Gang Wu, Shengsong Huang, Kent L. Nastiuk, Jinliang Li, Jun Gu, Ming Wu, Qimin Zhang, Hanqing Lin and Denglong Wu

    Article first published online : 1 MAR 2015, DOI: 10.1002/pros.22967

  16. Androgen receptor targeting drugs in castration-resistant prostate cancer and mechanisms of resistance

    Clinical Pharmacology & Therapeutics

    Volume 98, Issue 6, December 2015, Pages: 582–589, DJ Crona, MI Milowsky and YE Whang

    Article first published online : 1 OCT 2015, DOI: 10.1002/cpt.256

  17. You have free access to this content
    Novel agents for castration-resistant prostate cancer: Early experience and beyond

    International Journal of Urology

    Volume 23, Issue 2, February 2016, Pages: 114–121, Naohiro Fujimoto

    Article first published online : 27 AUG 2015, DOI: 10.1111/iju.12907

  18. You have free access to this content
    Optimizing the care of patients with advanced prostate cancer in the UK: current challenges and future opportunities

    BJU International

    Volume 110, Issue 5, September 2012, Pages: 658–667, Heather Payne, Amit Bahl, Malcolm Mason, Janis Troup and Johann De Bono

    Article first published online : 19 MAR 2012, DOI: 10.1111/j.1464-410X.2011.10886.x

  19. Adaptive auto-regulation of androgen receptor provides a paradigm shifting rationale for bipolar androgen therapy (BAT) for castrate resistant human prostate cancer

    The Prostate

    Volume 72, Issue 14, 1 October 2012, Pages: 1491–1505, John T. Isaacs, Jason M. D'Antonio, Shuangling Chen, Lizamma Antony, Susan P. Dalrymple, Georges H. Ndikuyeze, Jun Luo and Samuel R. Denmeade

    Article first published online : 6 MAR 2012, DOI: 10.1002/pros.22504

  20. You have free access to this content
    Targeting the androgen receptor signalling axis in castration-resistant prostate cancer (CRPC)

    BJU International

    Volume 110, Issue 11, December 2012, Pages: 1580–1588, Che-Kai Tsao, Matthew D. Galsky, Alexander C. Small, Tiffany Yee and William K. Oh

    Article first published online : 18 SEP 2012, DOI: 10.1111/j.1464-410X.2012.11445.x